secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001640334-25-001660
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences amends bylaws; eliminates stockholder written consent, adopts Nevada control share provisions
--------------------------------------------------------------------------------

- Board eliminated stockholders' right to act by written consent, effective immediately.
- Bylaws updated to treat Artelo as Nevada 'issuing corporation' under NRS 78.378-78.3793.
- Record date for shareholder meetings and dividends capped at 60 days prior to action.
- Notice period for special board meetings revised; details in filed amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001660/0001640334-25-001660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001660/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer